19-901511-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_138774.4(R3HDM4):c.262G>A(p.Gly88Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000189 in 1,608,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_138774.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
R3HDM4 | NM_138774.4 | c.262G>A | p.Gly88Ser | missense_variant | 3/8 | ENST00000361574.10 | NP_620129.2 | |
R3HDM4 | XM_011528416.3 | c.262G>A | p.Gly88Ser | missense_variant | 3/8 | XP_011526718.1 | ||
R3HDM4 | XM_024451771.2 | c.-105G>A | 5_prime_UTR_variant | 3/8 | XP_024307539.1 | |||
R3HDM4 | XM_047439659.1 | c.-16+465G>A | intron_variant | XP_047295615.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
R3HDM4 | ENST00000361574.10 | c.262G>A | p.Gly88Ser | missense_variant | 3/8 | 1 | NM_138774.4 | ENSP00000355385.4 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152080Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000103 AC: 25AN: 243018Hom.: 0 AF XY: 0.0000759 AC XY: 10AN XY: 131824
GnomAD4 exome AF: 0.000193 AC: 281AN: 1456126Hom.: 0 Cov.: 31 AF XY: 0.000181 AC XY: 131AN XY: 724306
GnomAD4 genome AF: 0.000151 AC: 23AN: 152198Hom.: 0 Cov.: 31 AF XY: 0.000161 AC XY: 12AN XY: 74398
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 17, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at